Heart shock drug trial halted after just 2 patients
NCT ID NCT04904562
First seen Apr 15, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This study tested a drug called angiotensin II to treat a dangerous drop in blood pressure (distributive shock) that can happen during or right after heart transplant or LVAD surgery. The goal was to see if it could reduce the need for other strong blood pressure medicines. Only 2 people were enrolled before the study was stopped early, so no clear conclusions can be drawn.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISTRIBUTIVE SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.